MedPath

MESNEX

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1988

Approved
Approval ID

2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 24, 2018

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MESNA

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0338-1307
Application NumberNDA019884
Product Classification
M
Marketing Category
C73594
G
Generic Name
MESNA
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 24, 2018
FDA Product Classification

INGREDIENTS (4)

MESNAActive
Quantity: 100 mg in 1 mL
Code: NR7O1405Q9
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 1.04 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.